Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysis

Effects of Baseline Thrombocytopenia on In-hospital Outcomes in Patients Undergoing Elective Percutaneous Coronary Intervention

(2019) Jun Shiraishi et al.   INTERNAL MEDICINE

New perspectives on treatment strategies for patient with acute myeloid leukemia and complex karyotype abnormalities after percutaneous coronary intervention

(2019) Jie Wang et al.   MEDICINE

Optimal duration of dual antiplatelet therapy post percutaneous coronary intervention in acute coronary syndrome

(2019) Pierre Deharo et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor

(2019) Matteo Bianco et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Impact of Baseline Thrombocytopenia on Bleeding and Mortality After Percutaneous Coronary Intervention

(2018) Shinya Ito et al.   AMERICAN JOURNAL OF CARDIOLOGY

Impact of Chronic Thrombocytopenia on In-Hospital Outcomes After Percutaneous Coronary Intervention

(2018) Karam Ayoub et al.   JACC-Cardiovascular Interventions

Impact of baseline thrombocytopenia on the long-term outcome of patients undergoing elective percutaneous coronary intervention: An analysis of 9,897 consecutive patients

(2018) Shuai Liu et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum

(2017) Cian P McCarthy et al.   EUROPEAN HEART JOURNAL

Effect of Baseline Thrombocytopenia on Ischemic Outcomes in Patients With Acute Coronary Syndromes Who Undergo Percutaneous Coronary Intervention

(2016) Mayank Yadav et al.   CANADIAN JOURNAL OF CARDIOLOGY

Short-versus long-term Dual Antiplatelet therapy after drug-eluting stent implantation in women versus men: A sex-specific patient-level pooled-analysis of six randomized trials

(2016) Fadi J. Sawaya et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Effect of Preprocedural Thrombocytopenia on Prognosis After Percutaneous Coronary Intervention

(2016) Claire E. Raphael et al.   MAYO CLINIC PROCEEDINGS

Anticoagulation Strategies for Primary Percutaneous Coronary Intervention: Current Controversies and Recommendations

(2015) H. L. Dauerman   Circulation-Cardiovascular Interventions

The Prognostic Value of Bleeding Academic Research Consortium (BARC)-Defined Bleeding Complications in ST-Segment Elevation Myocardial Infarction

(2014) Wouter J. Kikkert et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Thrombocytopenia in Patients With Atrial Fibrillation on Oral Anticoagulation Undergoing Percutaneous Coronary Intervention

(2013) Tuomas Kiviniemi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Koronarintervention bei einer Patientin mit akuter myeloischer Leukämie

(2012) P. Staib et al.   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: Analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial

(2011) Diaa A. Hakim et al.   AMERICAN HEART JOURNAL

Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention

(2011) G. CAMPO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Adverse Prognostic Significance of Thrombocytopenia in Acute Coronary Syndrome

(2009) Theodore E. Warkentin et al.   CIRCULATION

Thrombocytopenia at baseline is a predictor of inhospital mortality in patients undergoing percutaneous coronary intervention

(2008) Christopher B. Overgaard et al.   AMERICAN HEART JOURNAL